Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Initial evaluation of the use of USPIO cell labeling and noninvasive MR monitoring of human tissue-engineered vascular grafts in vivo.

Nelson GN, Roh JD, Mirensky TL, Wang Y, Yi T, Tellides G, Pober JS, Shkarin P, Shapiro EM, Saltzman WM, Papademetris X, Fahmy TM, Breuer CK.

FASEB J. 2008 Nov;22(11):3888-95. doi: 10.1096/fj.08-107367. Epub 2008 Aug 18.

2.

USPIO-labeled textile materials for non-invasive MR imaging of tissue-engineered vascular grafts.

Mertens ME, Koch S, Schuster P, Wehner J, Wu Z, Gremse F, Schulz V, Rongen L, Wolf F, Frese J, Gesché VN, van Zandvoort M, Mela P, Jockenhoevel S, Kiessling F, Lammers T.

Biomaterials. 2015 Jan;39:155-63. doi: 10.1016/j.biomaterials.2014.10.076. Epub 2014 Nov 21.

PMID:
25465443
3.

Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRI.

Harrington JK, Chahboune H, Criscione JM, Li AY, Hibino N, Yi T, Villalona GA, Kobsa S, Meijas D, Duncan DR, Devine L, Papademetri X, Shin'oka T, Fahmy TM, Breuer CK.

FASEB J. 2011 Dec;25(12):4150-61. doi: 10.1096/fj.11-185140. Epub 2011 Aug 16.

4.

FMN-coated fluorescent USPIO for cell labeling and non-invasive MR imaging in tissue engineering.

Mertens ME, Frese J, Bölükbas DA, Hrdlicka L, Golombek S, Koch S, Mela P, Jockenhövel S, Kiessling F, Lammers T.

Theranostics. 2014 Jul 28;4(10):1002-13. doi: 10.7150/thno.8763. eCollection 2014.

5.

In vivo MR imaging of tissue-engineered human mesenchymal stem cells transplanted to mouse: a preliminary study.

Ko IK, Song HT, Cho EJ, Lee ES, Huh YM, Suh JS.

Ann Biomed Eng. 2007 Jan;35(1):101-8. Epub 2006 Nov 3.

PMID:
17111211
6.
7.

Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents.

Frank JA, Zywicke H, Jordan EK, Mitchell J, Lewis BK, Miller B, Bryant LH Jr, Bulte JW.

Acad Radiol. 2002 Aug;9 Suppl 2:S484-7. No abstract available.

PMID:
12188316
8.

Investigation of atherosclerotic plaques with MRI at 3 T using ultrasmall superparamagnetic particles of iron oxide.

Priest AN, Ittrich H, Jahntz CL, Kooijman H, Weber C, Adam G.

Magn Reson Imaging. 2006 Dec;24(10):1287-93. Epub 2006 Oct 17.

PMID:
17145399
9.

Detection of vascular expression of E-selectin in vivo with MR imaging.

Reynolds PR, Larkman DJ, Haskard DO, Hajnal JV, Kennea NL, George AJ, Edwards AD.

Radiology. 2006 Nov;241(2):469-76. Epub 2006 Sep 27.

PMID:
17005768
10.

Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice.

de Lussanet QG, Backes WH, Griffioen AW, van Engelshoven JM, Beets-Tan RG.

Radiology. 2003 Nov;229(2):429-38.

PMID:
14595147
11.

Functional small-diameter human tissue-engineered arterial grafts in an immunodeficient mouse model: preliminary findings.

Nelson GN, Mirensky T, Brennan MP, Roh JD, Yi T, Wang Y, Breuer CK.

Arch Surg. 2008 May;143(5):488-94. doi: 10.1001/archsurg.143.5.488.

12.

Use of a blood-pool contrast agent for MR-guided vascular procedures: feasibility of ultrasmall superparamagnetic iron oxide particles.

Wacker FK, Wendt M, Ebert W, Hillenbrandt C, Wolf KJ, Lewin JS.

Acad Radiol. 2002 Nov;9(11):1251-4.

PMID:
12449357
13.

Transferrin receptor upregulation: in vitro labeling of rat mesenchymal stem cells with superparamagnetic iron oxide.

Schäfer R, Kehlbach R, Wiskirchen J, Bantleon R, Pintaske J, Brehm BR, Gerber A, Wolburg H, Claussen CD, Northoff H.

Radiology. 2007 Aug;244(2):514-23. Epub 2007 Jun 11.

PMID:
17562811
14.

Application of superparamagnetic iron oxide (AMI-227) for 3D phase-contrast MR angiography.

Tanimoto A, Yuasa Y, Hiramatsu K.

Acad Radiol. 1998 Apr;5 Suppl 1:S113-5. No abstract available.

PMID:
9561058
15.

Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice.

Persigehl T, Bieker R, Matuszewski L, Wall A, Kessler T, Kooijman H, Meier N, Ebert W, Berdel WE, Heindel W, Mesters RM, Bremer C.

Radiology. 2007 Aug;244(2):449-56. Epub 2007 Jun 11.

PMID:
17562810
16.

MR imaging with ultrasmall superparamagnetic iron oxide particles in experimental soft-tissue infections in rats.

Kaim AH, Wischer T, O'Reilly T, Jundt G, Fröhlich J, von Schulthess GK, Allegrini PR.

Radiology. 2002 Dec;225(3):808-14.

PMID:
12461265
17.

Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment.

Daldrup-Link HE, Rudelius M, Piontek G, Metz S, Bräuer R, Debus G, Corot C, Schlegel J, Link TM, Peschel C, Rummeny EJ, Oostendorp RA.

Radiology. 2005 Jan;234(1):197-205.

PMID:
15618382
18.

p38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment.

Morris JB, Olzinski AR, Bernard RE, Aravindhan K, Mirabile RC, Boyce R, Willette RN, Jucker BM.

Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):265-71. Epub 2007 Dec 27.

PMID:
18162612
19.

[MRI monitoring ultra-small superparamagnetic iron oxide (USPIO) particle labeling C6 rat glioma cells].

Zhang GX, Li YJ, Zhang F, Zhao JL, Li KA, Hu YS.

Zhonghua Yi Xue Za Zhi. 2007 Jan 23;87(4):228-32. Chinese.

PMID:
17425864
20.

Ultrasmall superparamagnetic iron oxide particles (AMI 227) as a blood pool contrast agent for MR angiography: experimental study in rabbits.

Loubeyre P, Zhao S, Canet E, Abidi H, Benderbous S, Revel D.

J Magn Reson Imaging. 1997 Nov-Dec;7(6):958-62.

PMID:
9400837

Supplemental Content

Support Center